By Rayk Riechmann As one of the brightest emerging biotechnology companies, Climb Bio Inc. (NASDAQ: CLYM) aims to improve the ...

John Arena is interim president of global pharma services at Cencora, managing a team that offers a broad range of solutions ...

Emergent BioSolutions' updated mission focuses on combating health threats like smallpox, Ebola, anthrax, and opioid ...

India's bio-economy has witnessed an extraordinary 16-fold surge over the past decade, growing from $10 billion in 2014 to an ...

By embracing biohacking trends strategically and ethically, brands can position themselves as leaders in the wellness ...

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will ...

The stock market is a dynamic landscape constantly shaped by economic trends, technological advancements, and shifting ...

LIfT's newly granted US patent (US 12,070,473 B2) secures robust protection for the treatment of cancer, including the use of ...

We recently compiled a list of the 10 Best Emerging Technology Stocks to Buy Now. In this article, we are going to take a ...

The emerging biotech's first commercial vaccine, for covid, received its first authorization in December 2020, and its early-stage pipeline and mRNA technology platforms have caught the eye of ...

Reshoring — the process of bringing manufacturing and supply chains back to the U.S. — has gained momentum in recent years.